SAGE
Assenagon Asset Management’s Sage Therapeutics SAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-120,723
| Closed | -$656K | – | 1293 |
|
|
2024
Q4 | $656K | Sell |
120,723
-65,316
| -35% | -$355K | ﹤0.01% | 1140 |
|
|
2024
Q3 | $1.34M | Buy |
186,039
+18,814
| +11% | +$136K | ﹤0.01% | 1050 |
|
|
2024
Q2 | $1.82M | Buy |
167,225
+10,632
| +7% | +$115K | ﹤0.01% | 917 |
|
|
2024
Q1 | $2.93M | Buy |
156,593
+143,075
| +1,058% | +$2.68M | 0.01% | 725 |
|
|
2023
Q4 | $293K | Buy |
+13,518
| New | +$293K | ﹤0.01% | 1286 |
|
|
2023
Q3 | – | Sell |
-32,605
| Closed | -$1.53M | – | 1411 |
|
|
2023
Q2 | $1.53M | Sell |
32,605
-71,126
| -69% | -$3.34M | 0.01% | 837 |
|
|
2023
Q1 | $4.35M | Buy |
103,731
+6,897
| +7% | +$289K | 0.02% | 587 |
|
|
2022
Q4 | $3.69M | Hold |
96,834
| – | – | 0.01% | 583 |
|
|
2022
Q3 | $3.79M | Sell |
96,834
-77,617
| -44% | -$3.04M | 0.01% | 523 |
|
|
2022
Q2 | $5.64M | Buy |
+174,451
| New | +$5.64M | 0.02% | 484 |
|
|
2021
Q4 | – | Sell |
-32,017
| Closed | -$1.42M | – | 1494 |
|
|
2021
Q3 | $1.42M | Buy |
32,017
+8,300
| +35% | +$368K | ﹤0.01% | 777 |
|
|
2021
Q2 | $1.35M | Buy |
23,717
+7,757
| +49% | +$441K | ﹤0.01% | 799 |
|
|
2021
Q1 | $1.2M | Buy |
+15,960
| New | +$1.2M | ﹤0.01% | 850 |
|